INTRODUCTION
Colorectal cancer (CRC) is the second leading cause of cancer death in the United States, and several studies have demonstrated that African Americans (AAs) have the highest rate of CRC in the United States [1] [2] [3] [4] [5] [6] . AAs have the highest incidence and death rates for CRC than Caucasian Americans (CAs), Hispanics and Asian/Pacific Islanders [7] . CRC typically correlates with age, reflecting a multistep progression from normal epithelium to carcinoma. However, a significant number of AAs are diag nosed with CRC at a younger age compared to CAs [8] [9] [10] [11] . Genomic alterations in oncogenes and tumor suppressor genes drive the epithelial cell transformation to carcinoma -including the Apc/Wnt-β-catenin signaling pathway and the tumor suppressor gene Apc [12] [13] [14] . Previous studies have shown that microRNA drivers upregulated in AAs lead to an increased proportion of cancer stem cells in human colonic epithelial cells [15] . The human microbiome is at the interface of intrinsic and environmental factors and abnormalities in the gut microbiome have been noted in patients with CRC [16] [17] [18] [19] . The colonic microbiota is mostly bacteria consisting of approximately 10 3 different microbial species [20] . Gut microbiota is essential in the maintenance of homeo stasis, and it contributes to immune development, inhibits pathogen colonization, processes drug meta bolites, metabolizes nutrients from the diet and also modulates their biological activities [10, 21] . Dysregulation of gut microbiota and a concomitant state of chronic inflammation and persistent activation of the host immune system have been implicated in the initiation and development of CRC [22] [23] [24] . One primary role of gut bacteria is to participate in the biotransformation of products in the gut, which include bile acids secreted from the liver. The gut micro biota may alter cancer susceptibility and has anticancer effect through the production of microbial secretory metabolites, such as short chain fatty acids (SCFAs), secondary bile acids (SBA), and trimethylamine Noxide (TAMO) [25] [26] [27] [28] . SBAs, deoxycholic acid (DCA) and lithocholic acid (LCA), are noted in particular for their carcinogenic activity [29] [30] [31] [32] [33] . Murine models have demonstrated that DCA shifts the microbiota community to dysbiosis and promotes intestinal tumorigenesis in Apc min/+ mice when DCAtreated fecal microbiota inoculated in one mouse is transferred to another [34] . Thus, multifactorial reasons underlie the racial disparity of CRC. The current investigation was aimed at studying microbial dysbiosis in the gut between AAs and CAs. In this pilot study, we investigate the diversity and abundance of specific gut microbes in colonic effluents using 16S rRNA gene community profiles in AAs and CAs and their possible role in increased incidence of CRC in AAs.
MATERIALS AND METHODS

Study subjects and collection of samples
In the current pilot investigation, 52 AA and 46 CA patients were recruited. The study was approved by the Institutional Review Boards and Committees of the John D. Dingell-Veterans Affairs Medical Center (JDD-VAMC) and Wayne State University School of Medicine. Patients excluded from the study were those with active malignant disease, inflammatory bowel disease, recent infection and those recently treated with antibiotics. In addition, patients with psychiatric or addictive disorder, hemorrhagic diathesis or on warfarin were excluded. General characteristics of study participants are the same as described in our earlier publication [15] . None of the patients were taking probiotics as supplements. General characteristics of each group of patients are presented in Table 1 .
Eligible study subjects were scheduled for an out patient screening colonoscopy at the JDD-VAMC. All study subjects received standard colonoscopy purgative preparation. Briefly, patients were asked to stay on a clear liquid diet for 24 h and to take a preparation containing 15 mg Bisacodyl the morning prior to their colonoscopy. The patients were also instructed to split the dose (4 L) of poly-ethylene glycol solution (PEG) into a first half (2 L) the evening prior to colonoscopy, and to drink the second half (the remaining 2 L) 5 h prior to the procedure and to finish it 3 h prior to the procedure, regardless of appointment time (morning or afternoon). Colonic effluent was aspirated prior to the colonoscopy through the working channel of the endoscope, as reported earlier [15] . Additionally, 8 forceps biopsies were taken from macroscopically normal appearing colonic mucosa (< 10 cm anal verge), as described previously [15] .
DNA extraction for 16S rRNA gene microbial community profiling
Genomic DNA was extracted from colonic effluents using QIAamp DNA Stool Mini Kit (QIAGEN) according to the manufacturer's instructions. Purified DNA used for analysis of 16S rRNA community profiling was per formed by LC Sciences (Houston, Texas). The V3 and V4 regions of the 16S rRNA gene were amplified to generate approximately 469 bp amplicons, automating cluster generation and sequencing on the MiSeq system. For data analysis, the merge pairedend reads from DNA fragments were analyzed using next generation sequencing FLASH (Fast Length Adjustment SHort reads) software, and raw sequencing data quality control was checked using FastQC software. Operational taxonomic units (OTUs) clustering was based on 97% sequence similarity using CDHIT software. Microbial strain identification software Quantitative Insights Into Microbial Ecology (QIIME) was used for alpha diversity and beta diversity, visualization of high throughput microbial com munity, and for principal coordinates analysis. Ribosomal Database Project (RDP) classifier, Greengenes, NCBI 16SMicrobial (TUIT tool) and GraPhlAn software were used for taxonomic classification and circular taxonomic phylogenetic trees.
Genomic DNA isolation from colonic effluents and validation
Bacterial genomic DNA was isolated from colonic effluents using QIAamp DNA Stool Mini Kit (QIAGEN) according to the manufacturer's instructions. For real time PCR, DNA (4050 ng) and appropriate blank were used for RTPCR analysis in triplicate using the 2 × PowerUp SYBR Green PCR Master Mix (Applied Biosystems) and the ABI Prism 7500 sequence detection system. PCR consisted of 40 cycles of 95 ℃ for 10 min and then 95 ℃ for 15 s, 60 ℃ for 60 s. The primer sequences were used to evaluate the presence of specific types of bacteria. Ct values were utilized to assess the relative concentration of specific DNA for each sample as described by the manufacturer. gene is listed in Table 2 .
Real-Time PCR from biopsy
To determine the specific bacterial abundance between serrated and tubular adenomatous patients, total RNA was prepared from patient biopsy samples using TRIzol as recommended by the manufacturer and purified using the Rneasy Mini Kit (QIAGEN). For real time PCR, cDNA was prepared with the SuperScript Ⅲ FirstStrand cDNA synthesis system for RTPCR (Invitrogen) and analyzed in triplicate using the 2 × PowerUp SYBR Green PCR Master Mix (Applied Biosystems) and the ABI Prism 7500 sequence detection system. Primers and PCR were performed as described in the previous section. For determination of RTPCR expression of 7α-dehydroxylase (BaiCD), primers were as follows, baiCD forward: 5'-GGWTTCAGCCCRCAGATGTTCTTTG-3'; reverse: 5'GAATTCCGGGTTCATGAACATTCTKCKAAG-3' [35] .
Statistical analysis
For microbiota data statistical analysis, Metastats soft ware was used for metagenomics sequencing data analyzed from two groups to characterize the microbial communities. CD-HT and R statistical software was used for BIOMformatted OTU communities clustering and OTU statistics. For examining alpha diversity, QIIME software was used for graphics and statistical purposes. RDP classifier, QIIME, TUIT GraPhlAn, MetaPhlAn, R software/Too were used for taxonomic classification and statistics. For Real Time PCR data, the standard deviation of mean between two groups and ttest were performed to determine the significance level between two groups.
RESULTS
Phylogenetic analysis of microbial communities in colonic effluents
Microbiota composition of colonic effluent was compared by high throughput analysis of 16S small ribosomal subunit gene (16S rRNA) amplicon. Sequencing of the V3 + V4 region was used for OTU clustering based on 97% sequence similarity. We found unique OTUs in AAs (7234) and CAs (5252), with an overlap of 742 OTUs between the two groups ( Figure 1A ). We found higher species richness and species diversity in CAs using the number of OTUs in Shannon index ( Figure 1B) . Irrespective of high inter-individual variances, the Principal Coordinates Analysis (PCoA) showed AAs to possess an abundance of common microbiota, compared to dispersed CA counter parts, revealing more microbial homogeneity within AAs than CA patients ( Figure 1C ).
The microbiota composition of AAs and CAs showed significant differences in the Bacteroidetes and Proteo bacteria phyla ( Figure 2A and Table 3 ). Taxonomic phylum from 11 from AAs and 24 from CAs were identified ( Figure 2A) . Bacteroidetes was the most abundant bacterial phylum in AAs (70%), whereas Firmicutes occurrence of 36% was higher in CAs ( Figure 2A ). Phylogenetic analysis further identified 44 classes of microbiota, with CAs showing more diverse population than AAs ( Figure 2B ). Bacteroidia was significantly higher in AAs, while Clostridia, Bacteriaunclassified, Gammaproteobacteria, Bacilli, Verrucomicrobiae, Acinobacteria, Fusobacteria and Alphaproteobacteria were more abundant in CAs ( Figure 2B ). Again, the microbial species richness and diversity was higher in CAs compared to AAs ( Figure 2B ).
By 16S rRNA gene profiling, there were eight pre dominant families found between the two racial groups, Bacteroidaceae, Ruminococcaceae, Lachnospiraceae, Rikenallaceae, Porphymonadaceae, streptococaceae, Acidaminococaceae and Veillonellaceae (Table 3) . The most predominant genus in AAs and CAs was Bacteroides, comprising 56% and 29%, respectively. Genus abundance of other microbiota was less than 7% with some degree of variation, as observed for Gemmiger, Allistipes, Parabacterroides, Faecalibacterium, Biophila, Ruminococcus2, Escherichia/Shigella (E/ S), Streptococcus, Clostridium IV, Clostridium XIVa, Barnesiella, Akkermansia, Phascolartobacterium, Veillonella, Blautica, Roseburia, Haemophilus, Dialister and Fusobacterium (Table 3) .
At the species levels, the relative abundance of B. caccae and B. massiliensis, P. distasonis, P. unclassified, Biophila unclassified and Clostridium XI unclassified were noted to be significantly higher in AAs compared to CAs (Table 3 Table 2 List of primers for bacterial genes specific for family, genus and species
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However, with respect to F. prausnitzii, Ruminococcus2 unclassified, A. putredinis, and P. clara, the relative abundance was found to be similar in both groups ( Table  3) . On the other hand, the Fusobacterium genus was For measurement of alpha diversity of observed species, QIIME software and Shannon index were used and the emperor tool generated the PCoA plot. AAs and CAs, we examined the abundance of specific bacterial populations using speciesspecific primers. The occurrence of the Enterobacter genus was found to be considerably higher in AAs than CAs ( Figure  3B ), while the Enterobacteriaceae family showed the opposite pattern (Table 3) . Taxonomic analysis showed CAs to contain Citrobacter, Klebsiela Escherichia coli, Enterobacter and Shigella sp. (Table 3 ). In contrast, the relative abundance of the probiotic bacteria genuses Bifidobacterium and Akkermansia muciniphila was considerably lower in AAs compared to CAs (Figures 3C and  D ). These observations demonstrate that the population of proinflammatory bacteria is higher in the gut of AAs than CAs.
Occurrence of Fusobacterium nucleatum and Clostridium genus
The relative abundance of Fusobacterium nucleatum has been associated with the development and progression of CRC [23, 36, 37] . We found that the relative abundance of F. nucleatum in colonic effluents was significantly higher in AAs than CAs (Figure 3E ), indicating a greater risk for the development of CRC in AAs. On the other hand, serrated polyps, which supposedly possess a greater risk of developing CRC, did not exhibit an increased abundancy of F. nucleatum. In fact, we found the relative abundance of F. nucleatum to be higher in tubular adenoma than serrated adenoma (BRaf proto oncogene, serine/threonine kinase (BRAF) mutation), whereas the probiotic Lactobacillus was lower in both serrated and tubular adenomas than those without adenoma ( Figure  4) . Likewise, the relative abundance of Bifidobacteria was found to be lower in tubular adenoma than those without adenoma ( Figure 4) . Using a clostridium cluster analysis and RT-PCR, we found that the relative abundance of Clostridium IV was higher in CAs ( Figure 5A ), while Clostridium XI was significantly higher in AAs ( Figure 5B ). Clostridium IV is known to be mediate antiinflammatory effects [38] [39] [40] . Clostridium sordelli in the Clostridium XI cluster group is known to transform SBA [41] . AA patients also showed higher concentrations of C. sordelli, compared to CAs ( Figure 5C ). A few species of gut anaerobes in the Clostridium genus promote the biotransformation of pri mary to SBA. Given the role of SBA (DCA and LCA) in promoting CRC, the expression of 7-α-dehydroxylase, an enzyme that participates in deconjugation of primary bile acids, was examined. We found the expression of 7-αdehydroxylase (baiCD) in colonic effluent from AA patients to be markedly higher than CA subjects ( Figure  5D ).
DISCUSSION
Our pilot study comparing AA and CA gut microbiota from colonic effluents reveal three major differences between the groups: the AA gut microbiota was less diverse overall, AAs had more pro-inflammatory gut bacteria, and AAs had fewer antiinflammatory gut bacteria. The phylogenetic tree of microbiota between AAs and CAs reveal an abundance of taxon in CA vs AA (Figure 6 ). Analyzing PCoA of patients, we noted trends found previously in comparing normal colon to adenomas and CRC [36, 42, 43] . Patients with colonic adenoma typically demonstrate reduced species richness and diversity compared to those without adenomas [44, 45] . Furthermore, a fecal microbiota shift occurs in patients with adenomas [46] , and they exhibit increased diversity in mucosa than those without adenoma [47] . The human gut microbiota composition is generally represented by three primary phyla: Firmicutes (30%50%), Bacteroidetes (20%40%), and Actino bacteria (1%10%) [22] . The two predominant bacterial phyla, Bacteroidetes, and Firmicutes, which contribute to 95% of the total GI ecosystem, are associated with adenomas and CRC [48] . The abundance of phylum Bacteroidetes (P. distasonis, Alistipes spp.) in the gut may increase the rate of tumorigenesis [49] . Our current study demonstrates an abundance of Bacteroidetes (70%) and reduction in Firmicute and Actinobacteria in AAs, whereas the microbial balance between pre dominant groups was unchanged in CAs, as has been demonstrated previously [22] . These observations are similar to what Hester et al [50] noted in their investigation in that the Firmicutes/Bacteroidetes ratio is higher in AAs compared to CAs. There is also a relative abundance of B. massiliensis in AAs compared to CAs. CRC has also been shown to be associated F. nucleatum and proinflammatory bacteria, Enterobacter and Clostridium XIspecies. F. nucleatum strains have been shown to promote carcinogenesis and invasion of host cells and potentiate tumorigenesis in mouse model of colon cancer [23, 37] . CRC patients demonstrate a higher abundance of F. nucleatum and Clostridium difficile, a member of Clostridium XI [51, 52] . Others have demonstrated that the relative increase in Clostridium cluster XI and Enterobacteriaceae are associated with intestinal dysbiosis [53] . Previous studies have suggested that a decrease in commensal microbiota in AAs may contribute to the tumorigenic microenvironment and that dysbiosis of gut microbiota may be partially responsible for promoting CRC and colitis-associated CRC [22, 42, 54] . In line with these observations, we found commensal bacteria B. fragilis to be slightly higher in CAs than AAs. Bacteroides fragilis is an immunomodulatory bacteria, which stimulates anti inflammatory cytokine IL10 by Foxp3+ regulatory CD+ T (Treg) cells and suppresses mucosal inflammation [55, 56] . In contrast, UnclassifiedBacteria and Unclassified Unclassified micro-organisms were only present in CAs A. municiphila, a member of Verrumicomicrobia, is an intestinal symbiont and is known to induce an anti inflammatory effect and enhance immune function [57] . Depletion of A. muciniphila is associated with a variety of diseases, including diabetes [58, 59] . We found the relative abundance of A. muciniphila to be lower in AAs than their CA counterparts. Collectively, AAs have fewer bacterial populations that are known to suppress inflammation, improve mucus barrier function, and diminish permea bility [60] .
Human genetic variants can modulate the effects of the microbiome composition, and both are associated with many human complex diseases [61] . Microbiota changes with diet and stimulatory agents and can modulate disease development and progression [61, 62] . Microbial dysbiosis in AAs may serve as a point for prevention and ultimately treatment of CRC. Identifying a microbial signature associated with CRC is complicated by many factors. This study was limited by focusing on a specific population with limited sample size and did not investigate dietary differences. However, there were significant differences between the colonic effluent microbiota of the AA and CA study groups with less diversity of bacteria, greater abundance of proinflam matory bacteria, and reduced antiinflammatory bacteria. Mechanisms for tumorigenesis may include bacteria that promote SBA transformation, as suggested by higher 7αdehydroxylase in the AA vs CA group. Further study is needed to evaluate the role of decreased diversity and structural imbalance in the colon microbial communities and the development of CRC.
ARTICLE HIGHLIGHTS
Research background
The incidence of colorectal cancer (CRC), the third most common malignancy, is not only higher among African Americans (AAs), but is also associated with higher mortality. In addition, AAs tend to be diagnosed with CRC at a younger age than Caucasian Americans (CAs) and exhibit worse prognoses than their CA counterparts. Despite this grim outlook, neither the extrinsic/intrinsic factor(s) nor the underlying molecular and/or biochemical mechanisms are fully understood. We hypothesize that imbalance in the gut microbiome between AAs and CAs results in alterations of metabolites, which changes symbiotic relationships and enhance gastrointestinal diseases, including CRC. A number of bacteria are known to promote carcinogenesis in the colon by altering gut microbial composition, which may play a major role in colorectal carcinogenesis.
Research motivation
CRC is the third leading malignancy world-wide, affecting both males and females equally. It represents one of the most common cancers in the United States and is estimated to be the second and third leading cause of cancerrelated deaths in men and women, respectively, in the United States. Several studies have also demonstrated that AAs have the highest rate of CRC than any other racial group in the USA, and also AA men are even more likely to die from CRC than AA women. With these grim statistics, it is important to gain a better understanding of the underlying mechanism(s), particularly the role of gut microbiota, in regulating racial disparity in colorectal carcinogenesis.
Research objectives
The current investigation was aimed at studying microbial dysbiosis in the gut between AAs and CAs. The primary endpoint of this investigation was to determine whether the increased incidence of CRC in AAs could be attributed to alterations in gut microbiota. In this pilot study, we investigated the diversity and abundance of specific gut microbial communities in colonic effluents using 16S rRNA gene profiling in AAs and CAs and their possible role in the increased incidence of CRC in AAs.
Research methods
Male and female AA and CA patients, aged between 40 and 80 years, undergoing routine colonoscopy at the John D. Dingell VA Medical Center in Detroit were asked to participate. To determine the microbial diversity and the microbial richness in AAs and CAs, colonic effluent from each patient was used for DNA extraction and 16s RNA gene-based microbial community profiling which was performed and analyzed by LC Sciences (Houston, Texas, United
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Farhana L et al . Gut microbial diversity and racial disparity States). The composition of OTU and alpha diversity was measured by Venn diagram and Rarefaction measurement method. The relative abundance of phylum and classes was depicted by bar and pie chart. The phylogenic tree was plotted for AA and CA to determine the relative abundance of family in microbial community. Several inflammatory and probiotic bacterial marker candidates such as Enterobacteria, Bifidobacteria, Lactobacillus, Fusobacterium and/or Clostridium genus and species-specific bacteria were identified by real-time qPCR using specific primers designed on the basis of conserved and variable region in bacterial 16S rRNA genes according to our standard protocol. Statistical analysis was performed for each experiment accordingly.
Research results
The relative abundance of Fusobacterium nucleatum, which has been associated with the development and progression of CRC, was found to be significantly higher in AAs than CAs, indicating a greater risk for the development of CRC in AAs. Clostridium IV, a known mediator of antiinflammatory effects, was found to be higher in CAs than AAs.
Research conclusion
The human colon harbors a complex microbial flora. Bacterial density in the human colon is among the highest found in nature, approaching 10 12 bacteria/gm wet weight of feces. These bacteria are in a symbiotic relationship with the intestine, utilizing undigested nutrients as substrates and in return, produce various vitamins, amino acids, transform bile salts and assist in the maintenance of the intestinal barrier, and the appropriate immune response against pathogens. This homeostasis is altered in a state of dysbiosis, which is overgrowth of pathogenic bacteria that are normally inhibited by commensal bacteria. Our current investigation, for the first time, demonstrates microbial dysbiosis between AAs and CAs. This imbalance, we believe, is partially responsible for the racial disparity in CRC observed between AAs and CAs.
Research perspective
Although numerous studies have demonstrated that the incidence of CRC is higher in AAs than CAs, the reasons for this racial disparity are not fully understood. Data generated from this investigation reveal a role for the gut microbiome in racial disparity. The precise mechanisms by which changes in gut microbiota would lead to an increase CRC in AAs remain unexplored. However, it is tempting to speculate that this dysbiosis or overgrowth of certain bacteria in the gut of AAs resulting in alterations in microbial metabolites, specifically deoxycholic acid and lithocholic acid, which are known for their cocarcinogenic activity, could induce the process(es) of carcinogenesis in the colon of AAs. However, the levels of microbial metabolites, including bile acids in AAs and CAs with and without adenomas have not determined. Moreover, no information is available whether the observed dysbiosis in AAs is due to changes in diet and/or lifestyle. Undoubtedly, further investigations are needed to gain a better and fuller understanding of the intrinsic and extrinsic factors that are critically involved in regulating racial disparity in CRC.
